Drug Insight: role of the androgen receptor in the development and progression of prostate cancer
Nature Clinical Practice Oncology · 2007-04 · 4 (4) · 236-244
DOI: 10.1038/ncponc0765 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Oncology, 2007-04. Verfasst von Mary-Ellen Taplin. Beteiligte Einrichtung: Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. mtaplin@partne…. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. mtaplin@partners.org
Zitieren
APA
Taplin, M. E. (2007). Drug Insight: role of the androgen receptor in the development and progression of prostate cancer. Nature Clinical Practice Oncology, 4(4), 236-244. https://doi.org/10.1038/ncponc0765
Vancouver
Taplin ME. Drug Insight: role of the androgen receptor in the development and progression of prostate cancer. Nature Clinical Practice Oncology. 2007;4(4):236-244. doi:10.1038/ncponc0765
BibTeX
@article{Taplin2007,
author = {Taplin, Mary-Ellen},
title = {Drug Insight: role of the androgen receptor in the development and progression of prostate cancer},
journal = {Nature Clinical Practice Oncology},
year = {2007},
volume = {4},
number = {4},
pages = {236--244},
doi = {10.1038/ncponc0765}
}
EUVIMED